Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Aug 15, 2026; 18(8): 118698
Published online Aug 15, 2026. doi: 10.4251/wjgo.118698
Published online Aug 15, 2026. doi: 10.4251/wjgo.118698
Table 4 Results of repeated-measures analysis of variance for blood pressure and tumor markers
| Outcome | Effect | F (df) | P value | η² |
| Systolic blood pressure | Time | 32.5 (1118) | 0.001 | 0.216 |
| Time × group | 6.8 (1118) | 0.010 | 0.055 | |
| Group | 5.3 (1118) | 0.023 | 0.043 | |
| Diastolic blood pressure | Time | 25.1 (1118) | 0.001 | 0.175 |
| Time × group | 5.1 (1118) | 0.026 | 0.041 | |
| Group | 4.2 (1118) | 0.043 | 0.034 | |
| CEA | Time | 28.3 (1118) | 0.001 | 0.193 |
| Time × group | 4.0 (1118) | 0.048 | 0.033 | |
| Group | 4.1 (1118) | 0.046 | 0.034 | |
| CA19-9 | Time | 34.7 (1118) | 0.001 | 0.227 |
| Time × group | 4.5 (1118) | 0.036 | 0.037 | |
| Group | 4.3 (1118) | 0.041 | 0.035 |
- Citation: Lou HC, Liu XH, Jin P, Wang JM, Liu B. Interaction between calcium channel blockers and capecitabine in colorectal cancer patients with hypertension. World J Gastrointest Oncol 2026; 18(8): 118698
- URL: https://www.wjgnet.com/1948-5204/full/v18/i8/118698.htm
- DOI: https://dx.doi.org/10.4251/wjgo.118698